CHE Chemed: Enterprise Value-to-Revenue Multiple

Official company branding of chemed.com (CHE)

The high barrier to entry is driven by stringent Medicare licensing and rigorous government quality control. On the GURU.Markets platform, the EV to total revenue multiple clearly demonstrates the business valuation trend, where 2832.38 records a new level. Chemed Corporation (CHE) generates revenue from government funding for palliative care and Roto-Rooter services, leveraging growing demand from an aging population and a stable consumer plumbing market.

VITAS Healthcare - CHE EV/Sales Multiple (period 11/23/2025 - 11/20/2026)

Chemed Corp - analytical breakdowns and key metrics (CHE)

- stock quotes and analyst forecast:
- company stock capitalization data:
Initial company analysis:CHE, chemed.com
Manufactured products of VITAS Healthcare

For long-term asset screening, it is critical to evaluate business value inclusive of net debt to determine the actual premium per unit of revenue. This EV/Sales ratio measures the total market value of the company relative to its sales, which, in the case of Chemed Corporation (CHE), confirms the efficiency of implementing AI automation in billing and hospice administration as reflected in the chart's dynamics.